Search

Your search keyword '"Gerold Schmitt-Ulms"' showing total 222 results

Search Constraints

Start Over You searched for: "Gerold Schmitt-Ulms" Remove constraint "Gerold Schmitt-Ulms"
222 results on '"Gerold Schmitt-Ulms"'

Search Results

1. The MEF2A transcription factor interactome in cardiomyocytes

2. Somatostatin slows Aβ plaque deposition in aged APP NL-F/NL-F mice by blocking Aβ aggregation

3. Advances in Recombinant Adeno-Associated Virus Vectors for Neurodegenerative Diseases

4. Aβ43 aggregates exhibit enhanced prion-like seeding activity in mice

5. Cardiac glycoside-mediated turnover of Na, K-ATPases as a rational approach to reducing cell surface levels of the cellular prion protein.

6. Loss of prion protein control of glucose metabolism promotes neurodegeneration in model of prion diseases.

7. Application of CRISPR genetic screens to investigate neurological diseases

9. The cellular prion protein interacts with and promotes the activity of Na,K-ATPases.

10. Rapid Generation of Human Neuronal Cell Models Enabling Inducible Expression of Proteins-of-interest for Functional Studies

11. Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression

12. A single protective polymorphism in the prion protein blocks <scp>cross‐species</scp> prion replication in cultured cells

13. The human brain somatostatin interactome: SST binds selectively to P-type family ATPases.

14. Octarepeat region flexibility impacts prion function, endoproteolysis and disease manifestation

15. Somatostatin binds to the human amyloid β peptide and favors the formation of distinct oligomers

16. Time-course global proteome analyses reveal an inverse correlation between Aβ burden and immunoglobulin M levels in the APPNL-F mouse model of Alzheimer disease.

17. Somatostatin slows Aβ plaque deposition in aged APPNL-F/NL-F mice by blocking Aβ aggregation in a neprilysin-independent manner

18. The <scp>IDIP</scp> framework for assessing protein function and its application to the prion protein

19. NCAM1 Polysialylation

20. Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining.

21. Prion Protein Deficiency Causes Diverse Proteome Shifts in Cell Models That Escape Detection in Brain Tissue.

22. Proteome‐wide identification of mycobacterial pupylation targets

23. The Prion Protein Controls Polysialylation of Neural Cell Adhesion Molecule 1 during Cellular Morphogenesis.

24. Identification of a Cardiac Glycoside Exhibiting Favorable Brain Bioavailability and Potency for Reducing Levels of the Cellular Prion Protein

25. The Evolutionary unZIPping of a Dimerization Motif—A Comparison of ZIP and PrP Architectures

26. CRISPR-Cas9-based knockout of the prion protein and its effect on the proteome.

27. Aβ43 aggregates exhibit enhanced prion-like seeding activity in mice

28. The aminoglycoside G418 hinders de novo prion infection in cultured cells

29. The ZIP5 ectodomain co-localizes with PrP and may acquire a PrP-like fold that assembles into a dimer.

30. An endogenous PI3K interactome promoting astrocyte-mediated neuroprotection identifies a novel association with RNA-binding protein ZC3H14

31. Combining molecular dynamics simulations and experimental analyses in protein misfolding

32. Rapid Generation of Human Neuronal Cell Models Enabling Inducible Expression of Proteins-of-interest for Functional Studies

33. PrionHome: a database of prions and other sequences relevant to prion phenomena.

34. The prion protein is embedded in a molecular environment that modulates transforming growth factor β and integrin signaling

35. Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression

36. Somatostatin in Alzheimer's disease: A new Role for an Old Player

37. Down-regulation of Shadoo in prion infections traces a pre-clinical event inversely related to PrP(Sc) accumulation.

38. Evidence for retrogene origins of the prion gene family.

39. Interactome analyses identify ties of PrP and its mammalian paralogs to oligomannosidic N-glycans and endoplasmic reticulum-derived chaperones.

41. Evolutionary descent of prion genes from the ZIP family of metal ion transporters.

42. Application of CRISPR genetic screens to investigate neurological diseases

43. Tau interactome analyses in CRISPR-Cas9 engineered neuronal cells reveal ATPase-dependent binding of wild-type but not P301L Tau to non-muscle myosins

44. The human brain somatostatin interactome: SST binds selectively to P-type family ATPases

45. Combining molecular dynamics simulations and experimental analyses in protein misfolding

46. CRISPR-Cas9 System: Opportunities and Concerns

47. DoesBDNFVal66Met contribute to preclinical Alzheimer’s disease?

48. Bcl-2-associated athanogene 5 (BAG5) regulates Parkin-dependent mitophagy and cell death

49. The Human Tau Interactome: Binding to the Ribonucleoproteome, and Impaired Binding of the Proline-to-Leucine Mutant at Position 301 (P301L) to Chaperones and the Proteasome

50. Current and future implications of basic and translational research on amyloid-β peptide production and removal pathways

Catalog

Books, media, physical & digital resources